Intravenous lacosamide (LCM) in status epilepticus (SE): Weight-adjusted dose and efficacy.

CONCLUSIONS: In adults with benzodiazepine-resistant SE, the response rate to LCM was higher, with weight-adjusted doses above 5.3 mg/kg. PMID: 29758445 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29758445?dopt=Abstract

Source: Epilepsy and Behaviour - May 11, 2018 Category: Neurology Authors: Santamarina E, González-Cuevas M, Toledo M, Jiménez M, Becerra JL, Quílez A, Suller A, Mauri JA, Fernández Á, Marinas A, Quintana M, Puig XS Tags: Epilepsy Behav Source Type: research